Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.01 0.00 (-0.49%)
As of: Nov 11, 2026 · 3:12 PM EST

Cardiol Therapeutics (CRDL) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Cardiol Therapeutics' Return on Capital Employed [ROCE] came in at -145.09% for Q2 2026, up 135.33 percentage points from -280.42% a year earlier and up 29.28 percentage points from the prior quarter.

Analysis

Cardiol Therapeutics (CRDL) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Cardiol Therapeutics' Return on Capital Employed [ROCE] was -157.47%, down 11.03 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined in each of the last three years, with a four-year change of -59.94 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -146.44% in FY2024 (-74.03 pp), -72.41% in FY2023 (-8.99 pp), -63.43% in FY2022 (+34.10 pp) and -97.53% in FY2021.
  • The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q1 2024.
  • Year-over-year, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -46.89 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2026 (a gain of 135.33 percentage points), and the weakest in Q3 2024 (a drop of 175.14 percentage points).
  • Business Quant data shows CRDL's Return on Capital Employed [ROCE] at -174.37% (Q1 2026), -268.63% (Q4 2025) and -271.16% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Cardiol Therapeutics 102.26 Mn 40.05 Mn - -145.09%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -145.09%
Mar 31, 2026 -174.37%
Dec 31, 2025 -268.63%
Sep 30, 2025 -271.16%
Jun 30, 2025 -280.42%
Mar 31, 2025 -199.24%
Dec 31, 2024 -231.57%
Sep 30, 2024 -257.40%
Jun 30, 2024 -177.93%
Mar 31, 2024 -130.30%
Dec 31, 2023 -93.68%
Sep 30, 2023 -82.26%
Jun 30, 2023 -88.26%
Mar 31, 2023 -80.42%
Dec 31, 2022 -78.25%
Sep 30, 2022 -75.91%
Jun 30, 2022 -64.52%
Mar 31, 2022 -54.02%
Dec 31, 2021 -81.35%
Sep 30, 2021 -110.01%
API Access

Cardiol Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEY